Exploring resonance theory and uncontrollability during co ‐creative art making: A qualitative study among cancer patients
ConclusionsIntegration of experiences of contingency into a life narrative can be supported by the process of co-creation of art, which invites patients to relate to their illness, their environment and themselves. The phases of resonance in combination with uncontrollability as a continuously present factor, provide a means to both study and support the integration of experiences of contingency into the life narrative. (Source: Cancer Medicine)
Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Yvonne Weeseman,
Michael Scherer ‐Rath,
Nirav Christophe,
Henny Dörr,
Esther Helmich,
Mirjam A. G. Sprangers,
Niels van Poecke,
Hanneke W. M. van Laarhoven Tags: RESEARCH ARTICLE Source Type: research
Oncological and functional outcomes for transoral robotic surgery following previous radiation treatment for upper aerodigestive tract head and neck cancers. A French multicenter GETTEC group study
ConclusionOncological and functional results confirmed the value of TORS as a treatment in previously irradiated area. (Source: Cancer Medicine)
Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Olivier Malard,
Matilde Karakachoff,
Christophe Ferron,
St éphane Hans,
Sébastien Vergez,
Renaud Garrel,
Philippe Gorphe,
Lionel Ramin,
Laure Santini,
Alexandre Villeneuve,
Audrey Lasne‐Cardon,
Florent Espitalier,
Audrey Hounkpatin Tags: RESEARCH ARTICLE Source Type: research
Comparison of the multiples of the median of serum anti ‐müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case–control study
ConclusionThis study showed combination chemotherapy led to a decreasing trend of MoM of serum AMH especially at 12 months after treatment, but the drop became static at 24 months. Although pregnancy is achievable, thorough counseling is still needed in this group especially those wish to achieve pregnancy 1–2 years after treatment or with other risk factors. (Source: Cancer Medicine)
Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Theodora Hei Tung Lai,
Lesley Suk Kwan Lau,
Siew Fei Ngu,
Man Yee Mandy Chu,
Karen Kar Loen Chan,
Ernest Hung Yu Ng,
Hextan Yuen Sheung Ngan,
Raymond Hang Wun Li,
Ka Yu Tse Tags: RESEARCH ARTICLE Source Type: research
The death burden of colorectal cancer attributable to modifiable risk factors, trend analysis from 1990 to 2019 and future predictions
ConclusionsThe attributable CRC death burden gradually shifted from higher SDI to lower SDI regions. The limitation in males was more significant, and the gap is expected to be further expanded. In lower SDI regions, the death burden tended to affect younger people. The leading cause of CRC-attributable deaths was the inadequate control of dietary and metabolic risk factors. (Source: Cancer Medicine)
Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Ning Zhu,
Yan Zhang,
Mi Mi,
Yuwei Ding,
Shanshan Weng,
Jia Zheng,
Yang Tian,
Ying Yuan Tags: RESEARCH ARTICLE Source Type: research
A longitudinal study of symptom cluster latent profiles in ovarian cancer patients undergoing chemotherapy
ConclusionsThis study underscores the existence of a diverse and heterogeneous experience within the symptom cluster of fatigue, pain, and sleep disturbance among ovarian cancer patients. Importantly, these patterns were stable throughout chemotherapy. Recognizing and understanding these patterns can inform the development of targeted interventions to alleviate the burden of symptom clusters in this population. (Source: Cancer Medicine)
Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Yue Feng,
Tangwei Lin,
Xingcan Liu,
Xiujing Guo,
Jing Chen,
Xue Deng Tags: RESEARCH ARTICLE Source Type: research
Early detection of nasopharyngeal carcinoma through machine ‐learning‐driven prediction model in a population‐based healthcare record database
ConclusionsML approaches using electronic medical records accurately predicted NPC occurrence. The risk prediction model serves as a low-cost digital screening tool, offering rapid medical decision support to shorten prediagnostic periods. Timely referral is crucial for high-risk patients identified by the model. (Source: Cancer Medicine)
Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Jeng ‐Wen Chen,
Shih‐Tsang Lin,
Yi‐Chun Lin,
Bo‐Sian Wang,
Yu‐Ning Chien,
Hung‐Yi Chiou Tags: RESEARCH ARTICLE Source Type: research
Issue Information
(Source: Cancer Medicine)
Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Tags: ISSUE INFORMATION Source Type: research
The feasibility and acceptability of an app ‐based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK
ConclusionsThis pilot study demonstrates that a large trial of the brisk walking intervention with behavioural support is both feasible and acceptable to people LWBC. The results support progression onto a confirmatory phase III trial to determine the efficacy and cost-effectiveness of the intervention. (Source: Cancer Medicine)
Source: Cancer Medicine - March 27, 2024 Category: Cancer & Oncology Authors: Phillippa Lally,
Fiona Kennedy,
Susan Smith,
Rebecca J. Beeken,
Caroline Buck,
Chloe Thomas,
Nicholas Counsell,
Lynda Wyld,
Charlene Martin,
Sarah Williams,
Anna Roberts,
Diana M. Greenfield,
Jacqui Gath,
Henry W. W. Potts,
Nicholas Latimer, Tags: RESEARCH ARTICLE Source Type: research
Prognostic significance of glucose ‐lipid metabolic index in pancreatic cancer patients with diabetes mellitus
ConclusionsIR is associated with the outcome of PC patients with diabetes and higher level of IR indicates worse prognosis. GLMI has a good predictive value for PC with diabetes. (Source: Cancer Medicine)
Source: Cancer Medicine - March 25, 2024 Category: Cancer & Oncology Authors: Hailiang Wang,
Shiye Ruan,
Zelong Wu,
Qian Yan,
Yubin Chen,
Jinwei Cui,
Zhongyan Zhang,
Shanzhou Huang,
Baohua Hou,
Chuanzhao Zhang Tags: RESEARCH ARTICLE Source Type: research
Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia
ConclusionsIn this real-world cohort, CUP presentations were heterogenous. Overall survival and rates of systemic treatment were poor. Poor performance status and unfavorable risk were associated with worse survival. For most patients, site-specific therapy did not improve survival outcome. Improved and timely access to diagnostic tests and therapeutics for this group of patients is urgently required. (Source: Cancer Medicine)
Source: Cancer Medicine - March 25, 2024 Category: Cancer & Oncology Authors: Emma L. Boys,
Bo Gao,
Peter Grimison,
Sarah Sutherland,
Karen L. MacKenzie,
Roger R. Reddel,
Jia Liu Tags: RESEARCH ARTICLE Source Type: research
Nomogram for predicting pathological response to neoadjuvant treatment in patients with locally advanced gastric cancer: Data from a phase III clinical trial
ConclusionA good pathological response after neoadjuvant treatment was associated with an improved prognosis in LAGC patients. The nomogram we established exhibits a high predictive capability for GR, offering potential value in devising personalized and precise treatment strategies for LAGC patients. (Source: Cancer Medicine)
Source: Cancer Medicine - March 25, 2024 Category: Cancer & Oncology Authors: Han Shao,
Nai Li,
Yi ‐hong Ling,
Ji‐jin Wang,
Yi Fang,
Ming Jing,
Zhi‐wei Zhou,
Yu‐jing Zhang Tags: RESEARCH ARTICLE Source Type: research
Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study
ConclusionDue to insufficient numbers, our study was not able to demonstrate any added value ofDPYD genotyping using complete genome sequencing to prevent 5-FU toxicity. The optimal strategy for DPD screening before fluoropyrimidine-based chemotherapy requires further clinical evaluation. (Source: Cancer Medicine)
Source: Cancer Medicine - March 25, 2024 Category: Cancer & Oncology Authors: C ôme De Metz,
Benjamin Hennart,
Estelle Aymes,
Pierre‐Yves Cren,
Niels Martignène,
Nicolas Penel,
Maël Barthoulot,
Aurélien Carnot Tags: RESEARCH ARTICLE Source Type: research
Patterns of B ‐cell lymphocyte expression changes in pre‐ and post‐malignant prostate tissue are associated with prostate cancer progression
ConclusionsLongitudinal and spatial expression patterns of both CD3+ and CD20+ suggest that increased expression in benign glands during prostate carcinogenesis is associated with an aggressive disease course. (Source: Cancer Medicine)
Source: Cancer Medicine - March 25, 2024 Category: Cancer & Oncology Authors: Sudha M. Sadasivan,
Ian M. Loveless,
Yalei Chen,
Nilesh S. Gupta,
Ryan Sanii,
Kevin R. Bobbitt,
Dhananjay A. Chitale,
Sean R. Williamson,
Andrew G. Rundle,
Benjamin A. Rybicki Tags: RESEARCH ARTICLE Source Type: research
Physical function patient ‐reported outcomes among adolescent and young adult cancer survivors: A systematic review
ConclusionsThe results overwhelmingly demonstrate that AYAs post a cancer diagnosis have worse health-related quality of life from a physical function perspective than their cancer-free peers, providing a compelling argument for the need to address this issue. All but one of the studies were cross-sectional, which highlights the need for further assessment of this group longitudinally throughout their cancer journey. (Source: Cancer Medicine)
Source: Cancer Medicine - March 23, 2024 Category: Cancer & Oncology Authors: Sarah Tanner,
Teyl Engstrom,
Cheryl Forbes,
Dhaval Patel,
Wen Ray Lee,
Rick Walker,
Natalie Bradford,
Jason D. Pole Tags: REVIEW Source Type: research
Comparisons of financial hardship in cancer care by family structure and among those with and without minor children using nationally representative data
ConclusionsOur findings suggest that having minor children, and being a single adult are risk factors for cancer-related financial hardship. Financial vulnerability associated with family structure should be taken into consideration in healthcare, and especially cancer care. (Source: Cancer Medicine)
Source: Cancer Medicine - March 23, 2024 Category: Cancer & Oncology Authors: Patricia I. Jewett,
Himal Purani,
Rachel I. Vogel,
Helen M. Parsons,
Maria Borrero,
Anne Blaes Tags: RESEARCH ARTICLE Source Type: research
